CB Pharma Acquisition, ticker symbol CNLMU, is set for its IPO on Tuesday November 25, 2014. The shares are expected to be priced at $10 per share, with 4 million shares set to go. This makes for a $40 million IPO.
This is a modest IPO, and it will test investor's appetite in this pharmaceutical company.
This is a modest IPO, and it will test investor's appetite in this pharmaceutical company.
This IPO is poised to be a good one.
ReplyDelete